ALK inhibitors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 10: | Line 10: | ||
*[[Inflammatory myofibroblastic tumour]]. | *[[Inflammatory myofibroblastic tumour]]. | ||
*[[ALK positive lung cancer]]. | *[[ALK positive lung cancer]]. | ||
*[[ALK translocation renal cell carcinoma]]. | |||
*[[ROS1-rearranged non-small cell lung carcinoma]]. | |||
==References== | ==References== | ||